Biomea Fusion IPO Info

Company Name: Biomea Fusion
Stock Symbol: BMEA
Exchange: NASDAQ
Status: Priced
IPO Date: 4/16/2021
IPO Price: 17.00 (-7.71%)
Underwriters
J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co.

Amount of Offering: N/A
Number of Shares Offered: 9 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Biomea Fusion is a preclinical-stage biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers.

News Headlines